Literature DB >> 23740218

Novel aspects of excitation-contraction coupling in heart failure.

Stefan Neef1, Lars S Maier.   

Abstract

Excitation-contraction coupling is the process by which electrical activation is translated into contraction of a cardiac myocyte and thus the heart. In heart failure, expression, phosphorylation, and function of several intracellular proteins that are involved in excitation-contraction coupling are altered. The present review article summarizes central principles and highlights novel aspects of alterations in heart failure, focusing especially on recent findings regarding altered sarcoplasmic reticulum Ca2+ -leak and late Na+ -current without being able to cover all changes in full detail. These two pathomechanisms seem to play interesting roles with respect to systolic and diastolic dysfunction and may also be important for cardiac arrhythmias. Furthermore, the article outlines the translation of these novel findings into potential therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23740218     DOI: 10.1007/s00395-013-0360-2

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  16 in total

Review 1.  Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation.

Authors:  Christopher E Woods; Jeffrey Olgin
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 2.  A multidimensional sight on cardiac failure: uncovered from structural to molecular level.

Authors:  Vijay Urmaliya; Gustavo Franchelli
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

Review 3.  Epigenetics of the failing heart.

Authors:  José Marín-García; Alexander T Akhmedov
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

4.  Improvement of cardiomyocyte function by a novel pyrimidine-based CaMKII-inhibitor.

Authors:  Stefan Neef; Alexander Steffens; Patricia Pellicena; Julian Mustroph; Simon Lebek; Katharina R Ort; Howard Schulman; Lars S Maier
Journal:  J Mol Cell Cardiol       Date:  2017-12-30       Impact factor: 5.000

Review 5.  Dysregulation of Mfn2 and Drp-1 proteins in heart failure.

Authors:  Srikanth Givvimani; Sathnur Pushpakumar; Sudhakar Veeranki; Suresh C Tyagi
Journal:  Can J Physiol Pharmacol       Date:  2014-05-09       Impact factor: 2.273

Review 6.  The heart as an extravascular target of endothelin-1 in particulate matter-induced cardiac dysfunction.

Authors:  Elizabeth A W Chan; Barbara Buckley; Aimen K Farraj; Leslie C Thompson
Journal:  Pharmacol Ther       Date:  2016-05-21       Impact factor: 12.310

Review 7.  Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart.

Authors:  Alexander T Akhmedov; Vitalyi Rybin; José Marín-García
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

8.  Ellagic Acid Prevents Ca2+ Dysregulation and Improves Functional Abnormalities of Ventricular Myocytes via Attenuation of Oxidative Stress in Pathological Cardiac Hypertrophy.

Authors:  Bilge E Yamasan; Tanju Mercan; Orhan Erkan; Semir Ozdemir
Journal:  Cardiovasc Toxicol       Date:  2021-04-28       Impact factor: 3.231

Review 9.  Cardiovascular remodelling in coronary artery disease and heart failure.

Authors:  Gerd Heusch; Peter Libby; Bernard Gersh; Derek Yellon; Michael Böhm; Gary Lopaschuk; Lionel Opie
Journal:  Lancet       Date:  2014-05-13       Impact factor: 79.321

10.  Low-Dose Empagliflozin Improves Systolic Heart Function after Myocardial Infarction in Rats: Regulation of MMP9, NHE1, and SERCA2a.

Authors:  Jana Goerg; Manuela Sommerfeld; Bettina Greiner; Dilyara Lauer; Yasemin Seckin; Alexander Kulikov; Dmitry Ivkin; Ulrich Kintscher; Sergey Okovityi; Elena Kaschina
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.